A detailed history of Lansforsakringar Fondforvaltning Ab (Publ) transactions in Incyte Corp stock. As of the latest transaction made, Lansforsakringar Fondforvaltning Ab (Publ) holds 56,738 shares of INCY stock, worth $3.51 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
56,738
Holding current value
$3.51 Million
% of portfolio
0.05%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Mar 14, 2025

BUY
$65.08 - $83.38 $3.69 Million - $4.73 Million
56,738 New
56,738 $3.92 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $13.8B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Lansforsakringar Fondforvaltning Ab (Publ) Portfolio

Follow Lansforsakringar Fondforvaltning Ab (Publ) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lansforsakringar Fondforvaltning Ab (Publ), based on Form 13F filings with the SEC.

News

Stay updated on Lansforsakringar Fondforvaltning Ab (Publ) with notifications on news.